Skip to Content

W 434 (Pantoprazole sodium delayed release 40 mg)

Pill imprint W 434 has been identified as Pantoprazole sodium delayed release 40 mg.

Pantoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; dumping syndrome; duodenal ulcer; gerd (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substance Act (CSA).

Pantoprazole sodium delayed release 40 mg W 434
Discount Card Promo
Pantoprazole sodium delayed release
W 434
40 mg
Elliptical / Oval
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Wockhardt USA
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide colloidal
calcium stearate
magnesium silicate
sodium starch glycolate type A potato
titanium dioxide
polyethylene glycol 4000
ferric oxide yellow
FD&C Blue No. 2
methacrylic acid - ethyl acrylate copolymer (1:1) type a
sodium hydroxide
triethyl citrate
polyethylene glycol 400
polyethylene glycol 6000
ferrosoferric oxide
ferric oxide red
propylene glycol

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.